Budapest, Hungary

Zoltan Sumeghy


Average Co-Inventor Count = 10.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1983-1984

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Zoltan Sumeghy: Innovator in Pharmaceutical Chemistry

Introduction

Zoltan Sumeghy is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on sulfur-containing isoquinoline derivatives. With a total of 2 patents, Sumeghy continues to push the boundaries of medicinal chemistry.

Latest Patents

Sumeghy's latest patents focus on sulfur-containing isoquinoline derivatives. The first patent concerns new sulfur-containing isoquinoline derivatives, specifically isoquinoline derivatives of the general formula (I), where R independently represents hydrogen, hydroxyl, or alkoxy having 1 to 4 carbon atoms. The second patent details a process for the preparation of isoquinolines of the same formula, emphasizing the versatility and potential applications of these compounds in pharmaceuticals.

Career Highlights

Zoltan Sumeghy is currently associated with Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt., a prominent pharmaceutical company in Hungary. His work at Chinoin has allowed him to collaborate with other talented professionals in the field, enhancing the impact of his research.

Collaborations

Some of Sumeghy's notable coworkers include Kalman Takacs and Maria H Papp. Their collaborative efforts contribute to the advancement of pharmaceutical innovations and the development of new therapeutic agents.

Conclusion

Zoltan Sumeghy is a distinguished inventor whose work in sulfur-containing isoquinoline derivatives has the potential to influence the pharmaceutical industry significantly. His contributions, along with his collaborations, highlight the importance of innovation in the field of medicinal chemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…